Как работает иммунитет — страница 25 из 27

Maizels R.M., McSorley H.J. Regulation of the host immune system by helminth parasites. // J Allergy Clin Immunol. 2016. Vol. 138, № 3. P. 666–675.

Mahanty S., Mollis S.N., Ravichandran M., Abrams J.S., Kumaraswami V., Jayaraman K., Ottesen E.A., Nutman T.B. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis // J Infect Dis. 1996. Vol. 173, № 3. P. 769–773.

Грин Н., Стаут У., Тейлор Д. Биология. 10 изд. в 3-х томах. – Издательство: Бином. Лаборатория знаний, 2018. – 1340 c.

Smallwood T.B., Giacomin P.R., Loukas A., Mulvenna J.P., Clark R.J., Miles J.J. Helminth immunomodulation in autoimmune disease. // Front Immunol. 2017. Vol. 8. Article 453.

RosenblumM.D., RemediosK.A., AbbasA.K. Mechanismsofhumanautoimmunity. // JClinInvest. 2015. Vol.125, № 6. P. 2228–2233.

Tang D., Rui Kang R., Coyne C.B., Zeh H.J., Lotze M.T. PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity. // Immunol Rev. 2012. Vol. 249, № 1. P. 158–175.

Candeias S.M., Gaipl U.S. The immune system in cancer prevention, development and therapy. // Anticancer Agents Med Chem. 2016. Vol.16, № 1. P. 101–107.

Oiseth S.J., Aziz M.S. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. // J Cancer Metastasis Treat 2017. Vol. 3. P. 250–261.

Leach D. R., Krummel M. F., Allison J. P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. // Science. 1996. Vol. 271, № 5256. P. 1734–1736; Iwai Y., Terawaki S., Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. // Int Immunol. 2005. Vol. 17, № 2. P. 133–144.

Li J., Li W., Huang K., Zhang Y., Kupfer G., Zhao Q. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward. // J Hematol Oncol. 2018. Vol. 11, № 1. Article 22; Saudemont A., Jespers L., Clay T. Current status of gene engineering cell therapeutics. // Front Immunol. 2018. Vol. 9. Article 153.

Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D. Smallpox and its Eradication. Geneva: World Health Organization, 1988. WHO Library Database.

Dinc G., Ulman Y.I. The introduction of variolation ‘A La Turca’ to the West by Lady Mary Montagu and Turkey’s contribution to this. // Vaccine. 2007. Vol. 25, P. 4261–4265.

Gross CP, Sepkowitz KA. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. IntJInfectDis 1998;3(1):54–60.

Dinc G., Ulman Y.I. The introduction of variolation ‘A La Turca’ to the West by Lady Mary Montagu and Turkey’s contribution to this. // Vaccine. 2007. Vol. 25, P. 4261–4265.

Микиртичан Г.Л. (2016). Из истории вакцинопрофилактики: оспопрививание. Российский педиатрический журнал. 2016. Том. 19, С. 55–62.

Stefan Riedel. (2005). Edward Jenner and the History of Smallpox and Vaccination. Baylor University Medical Center Proceedings. 18, 21–25.Pead PJ. Benjamin Jesty: new light in the dawn of vaccination. Lancet 2003; 362:2104–9.

http://www.who.int/archives/fonds_collections/bytitle/fonds_6/en/

https://www.bbc.com/news/uk-england-birmingham-45101091.

https://vaccine-safety-training.org/types-of-vaccine.html

http://www.who.int/ru/news-room/fact-sheets/detail/rabies.

http://www.who.int/features/qa/84/ru/.

http://www.who.int/immunization/global_vaccine_action_plan/ru/.

http://www.who.int/immunization/newsroom/thiomersal_information_sheet/ru/.

http://www.who.int/ru/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.

http://www.who.int/wer/2009/wer8415/en/.

http://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-b.

Baym M., Lieberman T.D., Kelsic E.D., Chait R., Gross R., Yelin I., Kishony R. Spatiotemporal microbial evolution on antibiotic landscapes. // Science. 2016. Vol. 353, № 6304. P. 1147–1151.

Pidot S.J., Gao W., Buultjens A.H., Monk I.R., Guerillot R., Carter G.P., Lee J.Y.H., Lam M.M.C., Grayson M.L., Ballard S.A., Mahony A.A., Grabsch E.A., Kotsanas D., Korman T.M., Coombs G.W., Robinson J.O., da Silva A.G., Seemann T., Howden B.P., Johnson P.D.R., Stinear T.P. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols. // Science Translational Medicine. 2018. Vol. 10, № 452. eaar6115.

Basha S., Surendran N., Pichichero M. Immune responses in neonates. // Expert Rev Clin Immunol. 2014. Vol. 10, № 9. P. 1171–1184.

Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. // Nat Rev Immunol. 2004. Vol.4, № 7. P. 553–564.

Simon A.K., Hollander G.A., McMichael A. Evolution of the immune system in humans from infancy to old age. // Proc Biol Sci. 2015. Vol. 282, № 1821. Article 20143085.

Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. // Nat Rev Immunol. 2007. Vol.7, № 5. P. 379–390.

Yang I., Corwin E.J., Brennan P.A., Murphy J.R. The infant microbiome: implications for infant health and neurocognitive development. // Nurs Res. 2016. Vol. 65, № 1. P. 76–88.

Reboldi A., Cyster J.G. Peyer’s patches: organizing B cell responses at the intestinal frontier. // Immunol Rev. 2016. Vol. 271, № 1. P. 230–245.

Eberl G., Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. // Mucosal Immunol. 2009. Vol. 2, № 6. P.478–48.

Ballard O., Morrow A.L. Human milk composition: nutrients and bioactive factors. // Pediatr Clin North Am. 2013. Vol. 60, № 1. P. 49–74; Martin C.R., Ling P-R., Blackburn G.L. Review of infant feeding: key features of breast milk and infant formula. // Nutrients. 2016. Vol. 8, № 5. Article 279.

http://www.who.int/immunization/.

Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. // Nat Rev Immunol. 2004. Vol.4, № 7. P. 553–564.; Simon A.K., Hollander G.A., McMichael A. Evolution of the immune system in humans from infancy to old age. // Proc Biol Sci. 2015. Vol. 282, № 1821. Article 20143085.

Okada H., Kuhn C., Feillet H., Bach J-F. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. // Clin Exp Immunol. 2010. Vol. 160, № 1. P. 1–9.

Джессика Снейдер Сакс. «Микробы хорошие и плохие» М.: АСТ: CORPUS, 2014. – 496 c.

Gell P.G.H., Coombs R.R.A. The classification of allergic reactions underlying disease. // Clinical Aspects of Immunology. BlackwellScience. 1963

Рёкен М., Гроверс Г., Бургдорф В.; Пер. с англ. Наглядная аллергология. М.: Бином. Лаборатория знаний. 2018, – 238 с.

Janeway C., Jr, Travers P., Walport M., Shlomchik M. Immunobiology, 5th edition. The Immune System in Health and Disease. New York: Garland Science; 2001.

Janeway C., Jr, Travers P., Walport M., Shlomchik M. Immunobiology, 5th edition. The Immune System in Health and Disease. New York: Garland Science; 2001.

Basu S., Kaur R., Kaur G. Hemolytic disease of the fetus and newborn: Current trends and perspectives. // Asian J Transfus Sci. 2011. Vol. 5, № 1. P. 3–7.

Stone S.F., Phillips E.J., Wiese M.D., Heddle R.J., Brown S.G.A. Immediate-type hypersensitivity drug reactions. // Br J Clin Pharmacol. 2014. Vol. 78, № 1. P. 1–13.

Kumar V. K., Abbas A. K., Aster J.C. Hypersensitivity: immunologicaly mediated tissue injury. Robbins & Cotran Pathologic Basis of Disease (9th ed.). Elsevier Health Sciences. 2014. P. 200–211.

Шенфельд И., Мерони П.Л., Чурилов Л.П… Руководство по аутоиммунным заболеваниям для врачей общей практики; пер. с англ. СПб.: Элби-СПб. 2017, – 416 с.

Uzzaman A., Cho S.H.Chapter 28: Classification of hypersensitivity reactions. // Allergy Asthma Proc. 2012. Vol. 33, Suppl 1. P. 96–99.

Orme I.M., Andersen P., Boom W.H. T cell response to Mycobacterium tuberculosis. // J Infect Dis. 1993. Vol. 167. P. 1481–1497.

Encinales L., Zuñiga J., Yunis M., Granados-Montiel J., Granados J., Almeciga I., Clavijo O., Awad C., Collazos V., Vargas-Rojas M.I., Bañales-Mendez J.L., Vazquez-Castañeda L., Stern J.N., Romero V., Frindkis-Hareli M., Terreros D., Fernandez-Viña M., Yunis E.J. Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. // Mol Immunol. 2010. Vol. 47, № 5. Article 1066.

Palm N.W., Rosenstein R.K., Medzhitov R. Allergic host defences. // Nature. 2012. Vol. 484, № 7395. P. 465–472.

Мечников И.И. «Этюды оптимизма» М.: Наука, Главная редакция литературы на ин. яз., 1988. – 328 с.; Мечников И.И. «Этюды о человеческой природе» СПб.: Азбука, Азбука-Аттикус, 2016. – 320 с.

Hillman E.T., Lu H., Yao T., Nakatsu C.H. Microbial ecology along the gastrointestinal tract // Microbes Environ. 2017. Vol. 32, № 4.P. 300–313.

Hillman E.T., Lu H., Yao T., Nakatsu C.H. Microbial ecology along the gastrointestinal tract // Microbes Environ. 2017. Vol. 32, № 4.P. 300–313.

TanakaM., Nakayama. Development of the gut microbiota in infancy and its impact on health in later life // J. Allergology International. 2017. Vol. 66, № 4. P. 515–522; Ramakrishna B.S. Role of the gut microbiota in human nutrition and metabolism // J Gastroenterol Hepatol. 2013. Vol. 28, № 4. P.9–17

Hillman E.T., Lu H., Yao T., Nakatsu C.H. Microbial ecology along the gastrointestinal tract // Microbes Environ. 2017. Vol. 32, № 4.P. 300–313.

Джессика Снейдер Сакс. «Микробы хорошие и плохие» М.: АСТ: CORPUS, 2014. – 496 c.

Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., Sherman P.M., Mayer E.A. An update on the use and investigation of probiotics in health and disease // Gut. 2013. Vol. 62 № 5: 787–796.

Degnan F.H. The US Food and Drug Administration and probiotics: regulatory categorization // Clin Infect Dis. 2008. Vol. 46, № 2: S133-136; discussionS144–151.